Month: October 2020

Jaguar Health Subsidiary Napo Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Crofelemer (Mytesi) for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy

A Significant Proportion of Patients Receiving Targeted Cancer Therapy Experience Diarrhea Initial Tranche of Non-dilutive Financing Transaction Increased from $5...

Mobile AI technology from Saykara helps Nephrology Associates of Delaware boost physician productivity and well-being, increase face time with patients

By automating production of clinical notes, the artificially intelligent voice assistant from Saykara reduces computer data entry by physicians and...

error: Content is protected !!